Novonix (NVNXF) Shares Outstanding (Weighted Average) (2020 - 2025)

Novonix has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $681.7 billion in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 85.47% year-over-year to $681.7 billion; the trailing twelve-month figure through Dec 2025 stood at $681.7 billion (up 85.47% YoY), and the FY2025 full-year result was $485.5 million, down 99.87% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $681.7 billion, up from $392.8 billion in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $681.7 billion in Q4 2025, with the low at $282.1 million in Q2 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $309.4 billion across 5 years, with a median of $353.0 billion in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) soared 150444.64% — and 2024, when it retreated 24.6%.
• Novonix's Shares Outstanding (Weighted Average) stood at $323.2 million in 2021, then soared by 150444.64% to $486.6 billion in 2022, then gained by 0.18% to $487.5 billion in 2023, then retreated by 24.6% to $367.5 billion in 2024, then soared by 85.47% to $681.7 billion in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $681.7 billion (Q4 2025), $392.8 billion (Q2 2025), and $367.5 billion (Q4 2024), per Business Quant data.